Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

National Research (NRC) Liabilities and Shareholders Equity: 2010-2024

Historic Liabilities and Shareholders Equity for National Research (NRC) over the last 15 years, with FY2024 value amounting to $132.5 million.

  • National Research's Liabilities and Shareholders Equity rose 297.5% to $135.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $544.8 million, marking a year-over-year increase of 1023.28%. This contributed to the annual value of $132.5 million for FY2024, which is 825.08% up from last year.
  • As of FY2024, National Research's Liabilities and Shareholders Equity stood at $132.5 million, which was up 825.08% from $122.4 million recorded in FY2023.
  • In the past 5 years, National Research's Liabilities and Shareholders Equity ranged from a high of $157.5 million in FY2021 and a low of $122.4 million during FY2023
  • For the 5-year period, National Research's Liabilities and Shareholders Equity averaged around $135.3 million, with its median value being $132.5 million (2024).
  • As far as peak fluctuations go, National Research's Liabilities and Shareholders Equity soared by 2054.3% in 2020, and later plummeted by 1718.87% in 2022.
  • National Research's Liabilities and Shareholders Equity (Annual) stood at $133.4 million in 2020, then increased by 18.08% to $157.5 million in 2021, then fell by 17.19% to $130.5 million in 2022, then fell by 6.15% to $122.4 million in 2023, then increased by 8.25% to $132.5 million in 2024.
  • Its Liabilities and Shareholders Equity stands at $132.5 million for FY2024, versus $122.4 million for FY2023 and $130.5 million for FY2022.